The final project plan of the relative effectiveness assessment of ‘Venetoclax in combination with an hypomethylating agent for treatment of adult patients with newly diagnosed acute myeloid leukaemia (AML) who are ineligible for intensive chemotherapy’ is now available for access.

The final assessment report will be published on 7th July, 2021.

PTJA16 – Project Plan